MAPT and Cognitive impairment: A follow-up study by Zetterberg et al. (2008) found that BACE1 activity was elevated in mild cognitive impairment (MCI) subjects and in AD patients, and that there was a positive correlation between BACE1 activity in cerebrospinal fluid (CSF) and total tau levels.